Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03132485

Ligand	Ligand name	Chain	PDB	Tanimoto
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.71
AXT	ASTAXANTHIN	A,B	1GKA	0.71
20E	(2beta,3beta,5beta,22R)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one	A,D	2R40	0.73
TES	TESTOSTERONE	A	1JTV	0.74
TES	TESTOSTERONE	A	2Q7L	0.74
TES	TESTOSTERONE	A	2Q7I	0.74
TES	TESTOSTERONE	A,B	1J96	0.74
TES	TESTOSTERONE	A	2Q7K	0.74
TES	TESTOSTERONE	A,B	1Q13	0.74
TES	TESTOSTERONE	H	1I9J	0.74
TES	TESTOSTERONE	A,B	1AFS	0.74
TES	TESTOSTERONE	H	1VPO	0.74
TES	TESTOSTERONE	A	2Q7J	0.74
TES	TESTOSTERONE	A,B	3BUR	0.74
TES	TESTOSTERONE	A	2AM9	0.74
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A,B	2VDY	0.71
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A	2V95	0.71
HYF	4-HYDROXY-5-ISOBUTYRYL-6-METHYL-1,3,7-TRIS-(3-METHYL-BUT-2-ENYL)-6-(4-METHYL-PENT-3-ENYL)-BICYCLO[3.3.1]NON-3-ENE-2,9-DIONE	A	1M13	0.8
AS4	ALDOSTERONE	A	2AA2	0.72
AS4	ALDOSTERONE	A	2Q1H	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.73
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.73
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.73
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.73
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.73
0MA	maslinic acid	A	2QN2	0.71
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.72
CDZ	3,5-dihydroxy-4,6,6-tris(3-methylbut-2-en-1-yl)-2-(2-methylpropanoyl)cyclohexa-2,4-dien-1-one	A	2QNV	0.71
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	A,D	1R1K	0.73
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,U	1Z5X	0.73
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,F,G,H	2NXX	0.73
1CA	DESOXYCORTICOSTERONE	A,B	1Y9R	0.71
1CA	DESOXYCORTICOSTERONE	A,B,C	2ABI	0.71
1CA	DESOXYCORTICOSTERONE	A	2Q3Y	0.71
1CA	DESOXYCORTICOSTERONE	A	2AA7	0.71
C0R	CORTICOSTERONE	A	2A3I	0.73
C0R	CORTICOSTERONE	A,B	1Y5R	0.73
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EAU	0.75
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB3	0.75
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB4	0.75
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	2AAX	0.75
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	1H61	0.75
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	3CMF	0.75
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	2Q1V	0.75
VTQ	RRR-ALPHA-TOCOPHERYLQUINONE	A,C,E	1OLM	0.72
HEQ	3-[18-(4-HYDROXY-2,6,6-TRIMETHYL-CYCLOHEX-1-ENYL)-3,7,12,16-TETRAMETHYL-OCTADECA-1,3,5,7,9,11,13,15, 17-NONAENYL]-2,4,4-TRIMETHYL-CYCLOHEX-2-ENONE	A,B	1M98	0.71
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.74
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.74
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.74